W. Schillemans
Papers
1
Total Citations
5
H-Index
1
About
W. Schillemans is a radiation oncology researcher whose work focuses on improving the safety and precision of stereotactic body radiotherapy (SBRT) for abdominopelvic cancers. Their key research areas include the management of oligometastatic disease and the mitigation of gastrointestinal toxicity from high-dose radiation. Schillemans’ most cited study, "Acute toxicity of the bowel after stereotactic robotic radiotherapy for abdominopelvic oligometastases" (2017), made a significant contribution by systematically correlating dose-volume histogram (DVH) parameters with the incidence of grade ≥2 acute and late bowel toxicity in patients treated for solitary or oligometastatic lesions outside the liver. This work provided critical insights into dose constraints for organs at risk, helping to refine treatment planning and reduce adverse effects. With 5 citations, the paper has influenced subsequent clinical protocols and research on SBRT safety. Schillemans’ research is particularly valuable for clinicians seeking to balance tumor control with patient quality of life, and their findings continue to inform the safe expansion of stereotactic radiotherapy to challenging abdominal and pelvic sites.
Research Focus
Key Achievements
Top Papers
- 1